Gabapentin Capsule
Product Images NDC 71335-1093
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71335-1093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 01)
Image 1 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 02)
Image 2 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 03)
This appears to be a table or chart with information related to a fixed dose period of Gabapentin for pain management. The table shows the different dosages administered and their corresponding mean pain scores during different time periods. However, without the complete table or context, it is difficult to provide a comprehensive description.*
Image 3 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 04)
This appears to be a figure from a study regarding the proportion of responders in controlled post-herpetic neuralgia studies, with different groups of patients being given different treatments (GBP 3600, PBO, GBP 1800, and GBP 2400). The figure shows that in Study 1, 14% of patients responded to treatment, while in Study 2, 32-34% of patients responded, with statistical significance indicated (p < 0.001).*
Image 4 (D45f499b 8612 479e 8dd2 4fe28b1f5f9c 05)
Label Image (Lbl713351093)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.